Filter
290
Filtered Results: 290
Text search:
FDC
Featured
Recommendations
45
New Publications
108
Language
Document type
No document type
221
Guidelines
24
Studies & Reports
20
Training Material
9
Manuals
6
Fact sheets
5
Strategic & Response Plan
3
Situation Updates
1
Resource Platforms
1
Countries / Regions
India
25
Tanzania
14
Kenya
12
South Africa
11
Namibia
9
Malawi
8
Zambia
6
Indonesia
6
Nepal
5
Ghana
5
Burkina Faso
5
Bangladesh
5
Uganda
5
Nigeria
4
Zimbabwe
4
Mozambique
4
Cambodia
4
Ethiopia
4
Philippines
3
Liberia
3
Sierra Leone
2
Global
2
Latin America and the Carribbean
2
Congo, Democratic Republic of
2
South–East Asia Region
2
Botswana
2
Myanmar / Burma
2
Eswatini/ Swaziland
2
Tajikistan
1
Timor Leste/ East Timor
1
Ukraine
1
Lesotho
1
Gambia
1
Rwanda
1
Cameroon
1
Albania
1
Senegal
1
Afghanistan
1
Haiti
1
Western and Central Europe
1
Paraguay
1
Gabon
1
Sri Lanka
1
Libya
1
Bhutan
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
83
TB
24
Drugs & Medical Equipment
23
Studies & Reports
22
Policies
17
Guidelines
16
Capacity Building
15
HIV & STI
11
Pediatrics
8
Women & Child Health
7
Hepatitis
5
Communicable Diseases
3
Pharmacy & Technologies
3
Paediatrics
2
Clinical Training
2
Maternal & Child Health
2
Training Manuals
2
Demograhic Health Surveys DHS
2
Information, Education and Communication (IEC)
2
Non-communicable Diseases
2
Laboratory Quality Assurance
2
Digital Health
1
Public Health
1
Emergency Health Kits
1
Under-5 nutrition
1
Buruli Ulcer
1
Diabetes
1
Community Health
1
Virology
1
Infection Control & Prevention (IPC)
1
Countries
1
Cardiovascular Diseases
1
Medical Devices & Equipment
1
Community Health
1
Humanitarian Crisis
1
Statistics
1
Other
1
Women & Child Health
1
Neurology & Psychology
1
Disease Prevention & Control
1
Hygiene Promotion
1
Toolboxes
Adults
16
Clinical Aspects, Treatment & Prevention
13
Country specific
13
Children
13
Antiretroviral Treatment ART
13
Treatment & Prevention
10
Drug resistant TB
9
Children & Adolescents
8
Reports & Studies
8
Childhood TB
6
Eastern Europe and central Asia
6
Prevention & Control
5
Essential Medicines
5
Treatment Guidelines HIV
4
Pharmacy Practice
4
Disease Prevention & Control
4
Training
4
TB/HIV Coinfection
4
Essential Medicines & Devices Lists
3
Prices and Patents
3
Health Worker
3
Malawi
3
TB & Prisoners
3
Policies & Strategies
2
Clinical Aspects
2
Policies
2
National Policies
2
Namibia
2
HIV
2
Reports
2
Essential List
2
Others
2
Quality Assurance
2
Policies and guidelines
2
Co-Morbidities (except TB)
2
Latin America & the Carribean
2
South-east Asia Region
2
TB
2
Kenya
2
ART Drug Resistance
1
Policies & Strategies
1
Explosives
1
South Africa
1
Opportunistic Infections
1
Policies & Programmes
1
Training Manuals
1
General Studies & Reports
1
Adherence
1
TB & Other Vulnerable Populations
1
Country Guidelines
1
Workplace
1
General
1
Studies
1
General
1
Infection Control General
1
COVID-19
1
Country Specific
1
Country specific documents
1
Guidelines
1
Essential Medicines & Medical Devices
1
Hospital Readiness/Essential Health Services
1
TB/HIV
1
Fair Allocation & Ethical Aspects
1
Handbooks & Manuals
1
Health Promotion
1
Midwives
1
Advocacy & Communication
1
Supply Chain & Store Management
1
Rational use of Medicine
1
HIV &TB
1
Pediatrics
1
Mental Disorders
1
Overview, Studies & Reports
1
Access to treatment and laboratory
1
Clinical Aspects & Diagnosis
1
Studies & Reports
1
Clinical Aspects & Diagnosis
1
Detection & Diagnosis
1
Botswana
1
Liberia
1
Ghana
1
General Aspects
1
Human Rights & the Right to Health
1
Prevention of mother-to-child transmission (PMTCT)
1
Research & Access
1
Lesotho
1
Uganda
1
HIV and coinfection
1
Others
1
Tajikistan
1
Western & Central Europe
1
Reports & Studies Children HIV
1
Lobby and Advocacy
1
Eastern Europe & Central Asia
1
SEAR (South-east Asia Region)
1
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The objective of the 2022 Compendium is to compile and highlight emerging innovative health technologies for low-resource settings. It presents a snapshot of technologies that are solutions to an unmet medical/health technology need or are likely to improve health outcomes and the quality of life. H...
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment ...
FDA’s compounding program aims to protect patients from unsafe, ineffective and poor quality compounded drugs, while preserving access to lawfully-marketed compounded drugs for patients who have a medical need for them. Here you can find informations to laws &policies, compliance action, ....
The Coronavirus is spreading globally. How can individuals, communities and humanitarian actors best respond to the COVID-19 outbreak? How can the Sphere Handbook guide our response?
This document has two sections: A. The first section covers fundamental principles which are crucial to a succe...
- A Skills Building Program for Clinicians and Non-Clinicians. Adherence guidelines- slide deck- training course for health providers
Médecins sans Frontières access campaign
Issue Brief
Accessed: 28.11.2019
It's time to deliver differently.
Accessed: 13.11.2019
Downloaded from https://aidsinfo.nih.gov/guidelines on 10/19/2019
Developed by the HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV—A Working Group of the Office
of AIDS Research Advisory Council (OARAC)
Vinay P. Saldanha( UNAIDS Regional Director- Eastern Europe & Central Asia)
Session 1 Wednesday 30/01/2019
30-31 January 2019, Bucharest
Accessed: 29.09.2019
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, ...
Management of Diabetes Mellitus-Tuberculosis
recommended
1st edition
This resource provides practical guidance for front line health workers responsible for the diagnosis, management and care of patients with these two diseases. Published in collaboration with the World Diabetes Foundation
“Continuum of HIV services refers to a comprehensive package of HIV prevention, diagnostic, treatment, care and support services provided for people at risk of HIV infection or living with HIV and their families”
August, 2018
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Октябрь 2017
Русский
Рекомендации EACS 9.0
